13F Pro

SEC Form 4 reporting owner

Prasad Raju

Prasad Raju has filed 20 Form 4 transactions reported between December 22, 2025 and August 7, 2026, as Chief Financial Officer of CRISPR Therapeutics AG.

Name as filed: Prasad Raju

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$3.0M
9 lines
Companies
1
with Form 4 filings
Latest transaction
Aug 7, 2026
transaction date

Roles and reported holdings

  • CRSPCRISPR Therapeutics AG
    Dec 22, 2025 – Aug 7, 2026

    Chief Financial Officer

    Held directly14,815 sh as of Aug 7, 2026 · Form 4

    24 months: $3.0M sold

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 7, 2026CRSPChief Financial OfficerGiftCode G · direct750—Form 4
May 29, 2026CRSPChief Financial OfficerGrant or awardCode A · direct19,500—Form 4
Mar 23, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct3,708$173K@ $46.78Form 4
Mar 20, 2026CRSPChief Financial OfficerGrant or awardCode A · direct27,500—Form 4
Mar 20, 2026CRSPChief Financial OfficerGrant or awardCode A · direct38,499—Form 4
Mar 20, 2026CRSPChief Financial OfficerOption exerciseCode M · direct6,250—Form 4
Mar 16, 2026CRSPChief Financial OfficerGiftCode G · direct750—Form 4
Mar 16, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct4,021$194K@ $48.26Form 4
Mar 16, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct5,848$282K@ $48.26Form 4
Mar 14, 2026CRSPChief Financial OfficerOption exerciseCode M · direct6,875—Form 4
Mar 14, 2026CRSPChief Financial OfficerOption exerciseCode M · direct10,000—Form 4
Jan 22, 2026CRSPChief Financial OfficerOption exerciseCode M · direct34,972$1.6M@ $45.15Form 4
Jan 6, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct5,763$347K@ $60.21Form 4
Jan 6, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct5,004$300K@ $60.00Form 4
Jan 6, 2026CRSPChief Financial OfficerOpen-market saleCode S · direct18,933$1.1M@ $60.18Form 4
Jan 6, 2026CRSPChief Financial OfficerOption exerciseCode M · direct6,339$281K@ $44.31Form 4
Jan 6, 2026CRSPChief Financial OfficerOption exerciseCode M · direct23,361$1.1M@ $45.15Form 4
Dec 22, 2025CRSPChief Financial OfficerOpen-market saleCode S · direct1,000$57K@ $56.89Form 4
Dec 22, 2025CRSPChief Financial OfficerOpen-market saleCode S · direct5,472$308K@ $56.33Form 4
Dec 22, 2025CRSPChief Financial OfficerOpen-market saleCode S · direct3,528$194K@ $55.10Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.